Medigus Ltd. (MDGS)

Market Cap	6.85M
Revenue (ttm)	69.70M
Net Income (ttm)	-8.63M
Shares Out	1.64M
EPS (ttm)	-2.70
PE Ratio	n/a
Forward PE	n/a
Dividend	$0.85 (20.34%)
Ex-Dividend Date	Dec 19, 2022

Volume	388
Open	4.25
Previous Close	4.34
Day's Range	4.18 - 4.25
52-Week Range	4.02 - 17.85
Beta	1.41
Analysts	Buy
Price Target	n/a
Earnings Date	May 1, 2023

About MDGS

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it develops, markets, and distributes software for internet ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 26
• Stock Exchange: NASDAQ
• Ticker Symbol: MDGS